COVI-PRONE trial on its back
The randomized COVI-PRONE clinical trial demonstrated no difference in the risk of endotracheal...
Read MoreMay 18, 2022
The randomized COVI-PRONE clinical trial demonstrated no difference in the risk of endotracheal...
Read MoreMay 18, 2022
Asymptomatic adults should not be screened for chronic obstructive pulmonary disease (COPD), the...
Read MoreMay 18, 2022
Patients with severe, uncontrolled asthma demonstrated overall 2.8-fold higher odds of improved...
Read MoreMay 18, 2022
The phase 3 Liberty Asthma VOYAGE trial reported that dupilumab reduced severe asthma exacerbation...
Read MoreMay 18, 2022
In a prospective, randomized controlled trial, morbidly obese patients with normal lung function...
Read MoreMay 18, 2022
Hydrocortisone treatment in preterm infants, starting on postnatal day 14 to 28, did not result in...
Read MoreMay 18, 2022
The international results of the first series of patients indicate that when lung transplantation...
Read MoreMay 18, 2022
A post hoc analysis of the SPRINTER trial suggests that the inhaled, interferon-β investigational...
Read MoreMay 18, 2022
In patients with uncontrolled moderate-to-severe asthma, the risk of asthmatic exacerbation was...
Read MoreMay 18, 2022
Findings from a phase 2, randomized, placebo-controlled trial in patients with idiopathic...
Read MoreMay 2, 2022
Certain blood biochemical markers may have an important role in the pathogenesis of schizophrenia...
Read MoreApr 28, 2022
Molecular classification served as a significant marker of survival following endometrial cancer...
Read MoreApr 27, 2022
Black women experience higher mortality from endometrial cancer (EC) than White women, according...
Read MoreApr 27, 2022
Recent findings support the notion of metastasectomy being linked with an overall survival (OS)...
Read MoreApr 26, 2022
Preoperative PET scanning among patients with high-risk, clinical stage 1 endometrial cancer (EC)...
Read MoreApr 26, 2022
Only one-third of patients with asthma treated with inhaled corticosteroids (ICS) had a regular or...
Read MoreApr 26, 2022
Inebilizumab, an anti-CD19, B-cell depleting monoclonal antibody for adults with aquaporin-4...
Read More